Our mission is to develop and translate innovative technologies through biomaterials design at the interface of nanoscience, engineering, biology, and medicine to address the unmet critical needs in healthcare.
Our lab specializes in engineering nanomaterials for delivery of nucleic acid and protein therapeutics, soft tissue regeneration, and immunoengineering. Specifically, we aim to understand the structure-property-function relationship of biomaterials and technology platforms to enhance their therapeutic efficacy and develop new methods for scalable manufacturing and translation.
We build upon the strong collaborative projects with top scientists and clinicians at Hopkins and beyond. We are part of the Institute for NanoBioTechnology (INBT) and Department of Materials Science and Engineering located on the engineering campus, and the Translational Tissue Engineering Center (TTEC) and Department of Biomedical Engineering located on the medical campus. Our research has a strong translational focus and enjoys strong collaborations with industry partners.
Selected Recent Publications
Hanwright PJ’, Qiu C’, et al., Sustained IGF-1 delivery ameliorates effects of chronic denervation and improves functional recovery after peripheral nerve injury and repair. Biomaterials. 280: 121244. 2021. PMID: 34794826.